Kymera Therapeutics, Inc. Common Stock (KYMR) is a publicly traded Healthcare sector company. As of July 7, 2026, KYMR trades at $117.27 with a market cap of $9.34B and a P/E ratio of -31.30. KYMR moved +1.90% today. Year to date, KYMR is +46.90%; over the trailing twelve months it is +156.22%. Its 52-week range spans $19.45 to $130.05. Analyst consensus is strong buy with an average price target of $127.67. Rallies surfaces KYMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KYMR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KYMR recently traded at $117.27. Market cap is $9.34B. P/E ratio is -31.30. Revenue is $39.21M.
| Metric | Value |
|---|---|
| Price | $117.27 |
| Market Cap | $9.34B |
| P/E Ratio | -31.30 |
| EPS | $-3.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.05 |
| 52-Week Low | $19.45 |
| Volume | 165.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $39.21M |
| Net Income | $-311.35M |
| Gross Margin | 0.00% |
14 analysts cover KYMR: 0 strong buy, 14 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $127.67.